SESSION 4. IMPORTANCE OF REAL-WORLD DATA SOURCES AND EVIDENCE BEYOND SPONTANEOUS REPORTING

Use of artificial intelligence to leverage RWD in pharmacovigilance for patient safety
November, Wednesday 19 | 14:10 - 14:30

Speakers

MARIE-LAURE KURZINGER
SANOFI - Associate VP, Head of Pharmacoepidemiology - General Medicines, Pharmacovigilance and Patient Safety